Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1985 | 12-1984 | 12-1983 | 12-1982 | 12-1981 | |
| Sales | 4,024,500 | 3,875,900 | 3,764,700 | 3,496,000 | 3,280,900 |
| Cost of Goods | 1,545,700 | 1,528,400 | 1,548,200 | 1,554,300 | 1,567,800 |
| Gross Profit | 2,478,800 | 2,330,700 | 2,216,500 | 1,921,300 | 1,698,700 |
| Operating Expenses | 1,599,500 | 1,505,300 | 1,456,700 | 1,330,200 | 1,197,300 |
| Operating Income | 880,000 | 842,600 | 760,000 | 611,800 | 516,600 |
| Interest Expense | 78,400 | 94,400 | 95,600 | 115,400 | 132,600 |
| Other Income | 79,800 | 65,700 | 38,200 | 53,900 | 58,300 |
| Pre-tax Income | 881,400 | 813,900 | 702,600 | 550,300 | 442,300 |
| Income Tax | 296,400 | 296,200 | 248,400 | 208,600 | 160,100 |
| Net Income Continuous | 579,700 | 511,400 | 448,400 | 336,300 | 276,500 |
| Net Income Discontinuous | 0 | 0 | 0 | 0 | -52,400 |
| Net Income | $579,700 | $511,400 | $448,400 | $336,300 | $224,100 |
| EPS Basic Total Ops | 0.15 | 0.13 | 0.12 | 0.09 | 0.06 |
| EPS Basic Continuous Ops | 0.15 | 0.13 | 0.12 | 0.09 | 0.08 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | -0.01 |
| EPS Diluted Total Ops | 0.15 | 0.13 | 0.12 | 0.04 | 0.03 |
| EPS Diluted Continuous Ops | 0.15 | 0.13 | 0.12 | 0.04 | 0.04 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -0.01 |
| EBITDA(a) | $880,000 | $842,600 | $760,000 | $611,800 | $516,600 |